Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice
Strategies to combat COVID-19 require multiple ways to protect vulnerable people from infection. SARS-CoV-2 is an airborne pathogen and the nasal cavity is a primary target of infection. The K18-hACE2 mouse model was used to investigate the anti-SARS-CoV-2 efficacy of astodrimer sodium formulated in...
Main Authors: | Jeremy R. A. Paull, Carolyn A. Luscombe, Alex Castellarnau, Graham P. Heery, Michael D. Bobardt, Philippe A. Gallay |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/8/1656 |
Similar Items
-
Topical Astodrimer Sodium, a Non-Toxic Polyanionic Dendrimer, Demonstrates Antiviral Activity in an Experimental Ocular Adenovirus Infection Model
by: Eric G. Romanowski, et al.
Published: (2021-06-01) -
Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial
by: Alex Castellarnau, et al.
Published: (2022-06-01) -
Engineering of Janus-Like Dendrimers with Peptides Derived from Glycoproteins of Herpes Simplex Virus Type 1: Toward a Versatile and Novel Antiviral Platform
by: Annarita Falanga, et al.
Published: (2021-06-01) -
Uptake of Cationic PAMAM-PLGA Nanoparticles by the Nasal Mucosa
by: Mohammed A. Albarki, et al.
Published: (2022-11-01) -
E3 Ubiquitin Ligase SPL2 Is a Lanthanide-Binding Protein
by: Michał Tracz, et al.
Published: (2021-05-01)